Current achievements and future perspectives in whole-organ bioengineering

Andrea Peloso, Abritee Dhal, Joao P. Zambon, Peng Li, Giuseppe Orlando, Anthony Atala, Shay Soker

Research output: Contribution to journalArticle

Abstract

Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developments in bioengineering and regenerative medicine could provide a solid base for the future creation of implantable, bioengineered organs. Whole-organ detergent-perfusion protocols permit clinicians to gently remove all the cells and at the same time preserve the natural three-dimensional framework of the native organ. Several decellularized organs, including liver, kidney, and pancreas, have been created as a platform for further successful seeding. These scaffolds are composed of organ-specific extracellular matrix that contains growth factors important for cellular growth and function. Macro- and microvascular tree is entirely maintained and can be incorporated in the recipient's vascular system after the implant. This review will emphasize recent achievements in the whole-organ scaffolds and at the same time underline complications that the scientific community has to resolve before reaching a functional bioengineered organ.

Original languageEnglish (US)
JournalStem Cell Research and Therapy
DOIs
StateAccepted/In press - Jun 1 2015
Externally publishedYes

Fingerprint

Bioengineering
Regenerative Medicine
Organ Transplantation
Immunosuppressive Agents
Scaffolds
Detergents
Extracellular Matrix
Blood Vessels
Pancreas
Cause of Death
Intercellular Signaling Peptides and Proteins
Perfusion
Tissue Donors
Transplantation (surgical)
Kidney
Liver
Growth
Macros
Network protocols

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Molecular Medicine
  • Cell Biology
  • Medicine (miscellaneous)

Cite this

Peloso, A., Dhal, A., Zambon, J. P., Li, P., Orlando, G., Atala, A., & Soker, S. (Accepted/In press). Current achievements and future perspectives in whole-organ bioengineering. Stem Cell Research and Therapy. https://doi.org/10.1186/s13287-015-0089-y

Current achievements and future perspectives in whole-organ bioengineering. / Peloso, Andrea; Dhal, Abritee; Zambon, Joao P.; Li, Peng; Orlando, Giuseppe; Atala, Anthony; Soker, Shay.

In: Stem Cell Research and Therapy, 01.06.2015.

Research output: Contribution to journalArticle

Peloso, Andrea ; Dhal, Abritee ; Zambon, Joao P. ; Li, Peng ; Orlando, Giuseppe ; Atala, Anthony ; Soker, Shay. / Current achievements and future perspectives in whole-organ bioengineering. In: Stem Cell Research and Therapy. 2015.
@article{786972ad9e1e413184571a2f89aa76fc,
title = "Current achievements and future perspectives in whole-organ bioengineering",
abstract = "Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developments in bioengineering and regenerative medicine could provide a solid base for the future creation of implantable, bioengineered organs. Whole-organ detergent-perfusion protocols permit clinicians to gently remove all the cells and at the same time preserve the natural three-dimensional framework of the native organ. Several decellularized organs, including liver, kidney, and pancreas, have been created as a platform for further successful seeding. These scaffolds are composed of organ-specific extracellular matrix that contains growth factors important for cellular growth and function. Macro- and microvascular tree is entirely maintained and can be incorporated in the recipient's vascular system after the implant. This review will emphasize recent achievements in the whole-organ scaffolds and at the same time underline complications that the scientific community has to resolve before reaching a functional bioengineered organ.",
author = "Andrea Peloso and Abritee Dhal and Zambon, {Joao P.} and Peng Li and Giuseppe Orlando and Anthony Atala and Shay Soker",
year = "2015",
month = "6",
day = "1",
doi = "10.1186/s13287-015-0089-y",
language = "English (US)",
journal = "Stem Cell Research and Therapy",
issn = "1757-6512",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Current achievements and future perspectives in whole-organ bioengineering

AU - Peloso, Andrea

AU - Dhal, Abritee

AU - Zambon, Joao P.

AU - Li, Peng

AU - Orlando, Giuseppe

AU - Atala, Anthony

AU - Soker, Shay

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developments in bioengineering and regenerative medicine could provide a solid base for the future creation of implantable, bioengineered organs. Whole-organ detergent-perfusion protocols permit clinicians to gently remove all the cells and at the same time preserve the natural three-dimensional framework of the native organ. Several decellularized organs, including liver, kidney, and pancreas, have been created as a platform for further successful seeding. These scaffolds are composed of organ-specific extracellular matrix that contains growth factors important for cellular growth and function. Macro- and microvascular tree is entirely maintained and can be incorporated in the recipient's vascular system after the implant. This review will emphasize recent achievements in the whole-organ scaffolds and at the same time underline complications that the scientific community has to resolve before reaching a functional bioengineered organ.

AB - Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developments in bioengineering and regenerative medicine could provide a solid base for the future creation of implantable, bioengineered organs. Whole-organ detergent-perfusion protocols permit clinicians to gently remove all the cells and at the same time preserve the natural three-dimensional framework of the native organ. Several decellularized organs, including liver, kidney, and pancreas, have been created as a platform for further successful seeding. These scaffolds are composed of organ-specific extracellular matrix that contains growth factors important for cellular growth and function. Macro- and microvascular tree is entirely maintained and can be incorporated in the recipient's vascular system after the implant. This review will emphasize recent achievements in the whole-organ scaffolds and at the same time underline complications that the scientific community has to resolve before reaching a functional bioengineered organ.

UR - http://www.scopus.com/inward/record.url?scp=84930074742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930074742&partnerID=8YFLogxK

U2 - 10.1186/s13287-015-0089-y

DO - 10.1186/s13287-015-0089-y

M3 - Article

JO - Stem Cell Research and Therapy

JF - Stem Cell Research and Therapy

SN - 1757-6512

ER -